Esther Cheng

Biochemistry, Genetics and Molecular BiologyPhysics and AstronomyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment”.

Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment

Cancer Letters(2024)10.1016/j.canlet.2024.216608

N/A

0.607DataRank · unranked

16 citations

Gu Xiao, Galina Khramtsova, John Nguyen, Rachel Martini, Brian Stonaker +21 more

Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

Cancer Research(2025)10.1158/0008-5472.can-24-0775

N/A

0.535DataRank · unranked

14 citations

Rachel Martini, Sarah E. Ackermann, Colin P. Tang, Marvel Tranquille, Adriana Irizarry +29 more